28 Feb 2025 • People with a specific combination of elevated blood pressure (BP) and fasting plasma glucose (FPG) – termed BG-type Metabolic Syndrome (MetS) face the highest mortality risks.

Key Findings:

• BG-type MetS patients had a 44% increased risk of all-cause mortality, 73% increased risk of cancer mortality, and 34% increased risk of cardiovascular disease mortality.
• Genetic data also confirmed that higher BP and FPG levels reduce the likelihood of living to the 90th percentile age by 41% and 32%, respectively.

These findings highlight the critical need to target BG-type MetS individuals to improve outcomes and reduce mortality.

Source: BMC | Read Full Story